Serena Toffanin
Overview
Explore the profile of Serena Toffanin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
9
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Napolitano A, Spiezia L, Biolo M, Radu C, Toffanin S, Campello E, et al.
Semin Thromb Hemost
. 2025 Jan;
PMID: 39884292
Anti-platelet factor 4 (PF4) antibody-mediated disorders are a heterogeneous group of diseases characterized by the presence of highly pathogenic immunoglobulins G directed against PF4 and/or PF4/heparin complexes. These antibodies are...
2.
Campello E, Zanetto A, Prokopenko Y, Ilich A, Moonla C, Bulato C, et al.
Thromb Haemost
. 2024 Dec;
PMID: 39719151
Background: Portal vein system-specific risk factors contributing to portal vein thrombosis in cirrhosis are poorly investigated. Aim: This study aimed to quantify contact system and intrinsic pathway activation in the...
3.
Zanetto A, Campello E, Bulato C, Willems R, Konings J, Roest M, et al.
J Hepatol
. 2024 Dec;
PMID: 39672204
Background & Aims: The clinical utility of thrombomodulin-modified thrombin generation (TM-TG) in cirrhosis is uncertain. We conducted a prospective study to evaluate the prognostic value of TM-TG in cirrhosis. Methods:...
4.
Zanetto A, Toffanin S, Campello E, Simioni P
Dig Liver Dis
. 2024 Jun;
56(9):1643-1644.
PMID: 38918126
No abstract available.
5.
Cadamuro M, Lasagni A, Radu C, Calistri A, Pilan M, Valle C, et al.
J Hepatol
. 2024 Jun;
81(5):872-885.
PMID: 38908437
Background & Aims: The underlying mechanisms and clinical impact of portal microthrombosis in severe COVID-19 are unknown. Intrapulmonary vascular dilation (IPVD)-related hypoxia has been described in severe liver diseases. We...
6.
Napolitano A, Toffanin S, Bulato C, Campello E, Simioni P, Spiezia L
Front Cardiovasc Med
. 2024 May;
11:1386733.
PMID: 38803660
Cardiac amyloidosis is a group of diseases characterized by the deposition of amyloid fibers in cardiac tissue. Two forms are mainly reported: light chain (AL) and transthyretin (ATTR) amyloidosis. Among...
7.
Zanetto A, Toffanin S, Campello E, Radu C, Gavasso S, Burra P, et al.
Dig Liver Dis
. 2024 Mar;
56(8):1327-1334.
PMID: 38553338
Background: Reticulated platelets (RePLT) are emergency circulating platelets released to contrast peripheral platelet destruction. Aim: We conducted a prospective study to [a] characterize RePLT in cirrhosis; [b] evaluate the association...
8.
Campello E, Zanetto A, Radu C, Toffanin S, Shalaby S, Gavasso S, et al.
Liver Int
. 2024 Mar;
44(7):1610-1623.
PMID: 38517208
Background: Extracellular vesicles (EVs) modulate inflammation, coagulation and vascular homeostasis in decompensated cirrhosis. Aim: To characterize the profile of plasmatic EVs in patients with decompensated cirrhosis and bacterial infections and...
9.
Zanetto A, Campello E, Bulato C, Willems R, Konings J, Roest M, et al.
J Thromb Haemost
. 2023 Oct;
22(2):480-492.
PMID: 37866518
Background: Patients with cirrhosis have a normal to increased thrombin generation (TG) capacity in platelet-poor plasma (PPP). By reflecting the contribution of all circulating blood cells, whole blood (WB) TG...
10.
Todaro A, Radu C, Ciccone M, Toffanin S, Serino M, Campello E, et al.
J Thromb Haemost
. 2023 Oct;
22(2):410-422.
PMID: 37866515
Background: Coagulation factor V (FV) deficiency is a rare bleeding disorder that is usually managed with fresh-frozen plasma. Patients with nonsense mutations may respond to treatment with readthrough agents. Objectives:...